Home / Import refusals / AEK-4692799-0/11/1

FDA Import Refusal AEK-4692799-0/11/1 — Viatris Pharmaceuticals LLC

Viatris Pharmaceuticals LLC — FEI 2627208

The FDA refused shipment AEK-4692799-0/11/1 from Viatris Pharmaceuticals LLC (United States) on February 14, 2024. The refused product falls under Drugs and Biologics — DOXAZOSIN MESYLATE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 14, 2024
Country
United States
Product Category
Drugs and Biologics
Product Code
62ODY27 DOXAZOSIN MESYLATE (ANTI-HYPERTENSIVE - PART II)
Charges
75

Recent inspections

  • 1273532 (NAI Fri Jun 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1115559 (VAI Fri Dec 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046857 (VAI Wed Mar 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002319 (NAI Thu Dec 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935961 (VAI Thu Jul 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-7732651-8/10002/1 (Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-5902776-1/41/1 (Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-3057736-3/41/1 (Fri May 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2594296-0/41/1 (Fri Jan 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2684768-9/11/1 (Fri Jan 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources